HIGHLIGHTS
- who: Caisheng Lu and colleagues from the Columbia Center forColumbia University Ohio, USA Janssen Research and Development, Spring House, Pennsylvania, USA. Herbert Irving Columbia Cancer Center, Cancer Biostatistics Shared Resource, New York, New York, USA. have published the paper: IFN-u03b3R/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graftversus-host disease, in the Journal: (JOURNAL)
- future: Based on the studies the time point of studying MHC II expression will be crucial.
SUMMARY
IFN-γ is the only type II IFN family member produced by innate NK, γδ-T_cells, activated Th1 cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.